Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on April 2, 2013. The report discloses a definitive agreement to sell the company's contract packaging business, AndersonBrecon Inc. and AndersonBrecon (UK) Limited, to an investor group led by Frazier Healthcare VI, L.P.
Key Financial Metrics
- Transaction Value: $308 million in cash, subject to customary working capital adjustments.
- Accounting Treatment: AndersonBrecon results are reported within discontinued operations.
- Impact on Guidance: The transaction has no impact on fiscal 2013 financial performance expectations; any gain will be recorded in discontinued operations upon closing.
- Other Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes
The primary material change is the divestiture of the AndersonBrecon business unit. The transaction is expected to close in the third quarter of fiscal 2013, subject to customary closing conditions including regulatory reviews.
Outlook and Management Commentary
Management confirmed that the sale agreement does not alter the company's revised financial expectations for fiscal 2013, which were previously reported on April 1, 2013. The investor group acquiring the business includes affiliates of Greenspring Associates, QIC Global Private Equity, and Thomas McNerney & Partners.
Investor Verification Checklist
- Verify the final closing date of the AndersonBrecon transaction in the third quarter of fiscal 2013.
- Confirm the final purchase price after customary working capital adjustments.
- Review the April 1, 2013 Form 8-K for the specific fiscal 2013 financial expectations referenced in this filing.
- Monitor regulatory approval status as a condition for closing.